Hematological involvement in sarcoidosis: from cytopenias to lymphoma

References

• Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet (London, England). 2003;361(9363):1111–1118. doi: 10.1016/S0140-6736(03)12888-7
   PubMed Web of Science ®Google Scholar
• Dubrey S, Shah S, Hardman T, et al. Sarcoidosis: the links between epidemiology and aetiology. Postgrad Med J. 2014;90(1068):582–589. doi: 10.1136/postgradmedj-2014-132584
   PubMed Web of Science ®Google Scholar
• Brito-Zeron P, Kostov B, Superville D, et al. Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants. Clin Exp Rheumatol. 2019;37(6):1052–1064.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Kostov B, Brito-Zeron P, et al. How the frequency and phenotype of sarcoidosis is driven by environmental determinants. Lung. 2019;197(4):427–436. doi: 10.1007/s00408-019-00243-2
   PubMed Web of Science ®Google Scholar
• Lhote R, Annesi-Maesano I, Nunes H, et al. Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort. Eur Respir J. 2021;57(4):2001160. doi: 10.1183/13993003.01160-2020
   PubMed Web of Science ®Google Scholar
• Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer. 1974;29(3):247–251. doi: 10.1038/bjc.1974.64
   PubMed Web of Science ®Google Scholar
• Lower EE, Smith JT, Martelo OJ, et al. The anemia of sarcoidosis. Sarcoidosis. 1988;5(1):51–55.
   PubMedGoogle Scholar
• Bonifazi M, Bravi F, Gasparini S, et al. Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. Chest. 2015;147(3):778–791. doi: 10.1378/chest.14-1475
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Srivali N, Wijarnpreecha K, et al. Is the incidence of malignancy increased in patients with sarcoidosis? A systematic review and meta-analysis. Respirology. 2014;19(7):993–998. doi: 10.1111/resp.12369
   PubMed Web of Science ®Google Scholar
• Mahévas M, Chiche L, Uzunhan Y, et al. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients. Medicine (Baltimore). 2011;90(4):269–278. doi: 10.1097/MD.0b013e31822618b3
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Pérez-Alvarez R, Feijoo-Massó C, et al. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients. Jt Bone Spine. 2021;88(6):105236. doi: 10.1016/j.jbspin.2021.105236
   PubMed Web of Science ®Google Scholar
• Gupta D, Rao VM, Aggarwal AN, et al. Haematological abnormalities in patients of sarcoidosis. Indian J Chest Dis Allied Sci. 2002;44(4):233–236.
   PubMedGoogle Scholar
• Kahi CJ, Saxena R, Temkit M, et al. Hepatobiliary disease in sarcoidosis. Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG. 2006;23(2):117–123.
   PubMed Web of Science ®Google Scholar
• Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG/World Assoc Sarcoidosis Other Granulomatous Disord. 2012;29(2):119–127.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885–1889. doi: 10.1164/ajrccm.164.10.2104046
   PubMed Web of Science ®Google Scholar
• Pietinalho A, Ohmichi M, Hirasawa M, et al. Familial sarcoidosis in Finland and Hokkaido, Japan–a comparative study. Respir med. 1999;93(6):408–412. doi: 10.1053/rmed.1999.0579
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Carmona EM, Utz JP, et al. Epidemiology of sarcoidosis 1946-2013: a population-based study. Mayo Clin Proc. 2016;91(2):183–188. doi: 10.1016/j.mayocp.2015.10.024
   PubMed Web of Science ®Google Scholar
• Pavlovic-Popovic Z, Zaric B, Kosjerina Z, et al. Splenomegaly in sarcoidosis: frequency, treatment, prognosis and long-term follow-up. Srp Arh Celok Lek. 2015;143(5–6):279–283. doi: 10.2298/SARH1506279P
   PubMed Web of Science ®Google Scholar
• Webb AK, Mitchell DN, Bradstreet CM, et al. Splenomegaly and splenectomy in sarcoidosis. J Clin Pathol. 1979;32(10):1050–1053. doi: 10.1136/jcp.32.10.1050
   PubMed Web of Science ®Google Scholar
• Selroos O. Sarcoidosis of the spleen. Acta Med Scand. 1976;200(5):337–340. doi: 10.1111/j.0954-6820.1976.tb08243.x
   PubMedGoogle Scholar
• Kataria YP, Whitcomb ME. Splenomegaly in sarcoidosis. Arch Intern Med. 1980;140(1):35–37. doi: 10.1001/archinte.1980.00330130037013
   PubMedGoogle Scholar
• Tetikkurt C, Yanardag H, Pehlivan M, et al. Clinical features and prognostic significance of splenic involvement in sarcoidosis. Monaldi Arch Chest Dis = Arch Monaldi Per le Mal Del Torace. 2017;87(3):893. doi: 10.4081/monaldi.2017.893
   PubMedGoogle Scholar
• Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG/World Assoc Sarcoidosis Other Granulomatous Disord. 2014;31(1):19–27.
   PubMed Web of Science ®Google Scholar
• Grozdic Milojevic I, Sobic-Saranovic D, Videnovic-Ivanov J, et al. FDG PET/CT in bone sarcoidosis. Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG. 2016;33(1):66–74.
   PubMed Web of Science ®Google Scholar
• Yanardağ H, Pamuk GE, Karayel T, et al. Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples. Haematologia (Budap). 2002;32(4):419–425.
   PubMedGoogle Scholar
• Browne PM, Sharma OP, Salkin D. Bone marrow sarcoidosis. JAMA. 1978;240(24):2654–2655. doi: 10.1001/jama.1978.03290240054026
   PubMed Web of Science ®Google Scholar
• de Prost N, Kerrou K, Sibony M, et al. Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in sarcoidosis patients with anaemia. Respiration. 2010;79(1):25–31. doi: 10.1159/000204901
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lower EE, Li H, et al. Clinical characteristics of patients with bone sarcoidosis. Semin Arthritis Rheum. 2017;47(1):143–148. doi: 10.1016/j.semarthrit.2017.02.004
   PubMed Web of Science ®Google Scholar
• Brito-Zeron P, Acar-Denizli N, Siso-Almirall A, et al. The burden of comorbidity and complexity in sarcoidosis: impact of associated chronic diseases. Lung. 2018;196(2):239–248. doi: 10.1007/s00408-017-0076-4
   PubMed Web of Science ®Google Scholar
• NOTKIN M, OFFENDRANTZ FM, ABRAMO A. Sarcoid spleen with thrombocytopenic purpura. J Med Soc N J. 1950;47(6):272–275.
   PubMedGoogle Scholar
• KUNKEL P, YESNER R. Thrombocytopenic purpura associated with sarcoid granulomas of the spleen. AMA Arch Pathol. 1950;50(6):778–786.
   PubMedGoogle Scholar
• Barlas A, Ramachandran L. Immune Thrombocytopenic Purpura Secondary to Sarcoidosis. Maedica (Buchar). 2022;17(1):234–236. doi: 10.26574/maedica.2022.17.1.234
   PubMedGoogle Scholar
• Korogodina A, Kaur N, Kumthekar A. Sarcoidosis-Associated Immune Thrombocytopenic Purpura and Focal Segmental Glomerulosclerosis. J Investig Med High Impact Case Reports. 2022;10:23247096221097520. doi: 10.1177/23247096221097522
   Web of Science ®Google Scholar
• Erlich-Malona N, Cahill J, Chaudhry S, et al. Cardiac sarcoidosis requiring ICD placement and immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis. Mult Scler Relat Disord. 2021;47:102599. doi: 10.1016/j.msard.2020.102599
   PubMed Web of Science ®Google Scholar
• Medhat BM, Behiry ME, Fateen M, et al. Sarcoidosis beyond pulmonary involvement: A case series of unusual presentations. Respir Med Case Reports. 2021;34:101495. doi: 10.1016/j.rmcr.2021.101495
   PubMed Web of Science ®Google Scholar
• Silva Leal M, Amado C, Paracana B, et al. Immune thrombocytopenia: a rare presentation of pulmonary sarcoidosis. Eur J Case Reports Intern Med. 2021;8(12):3060. doi: 10.12890/2021_003060
   Google Scholar
• Chen JJ, Allen RC. Ocular sarcoidosis and immune thrombocytopenia: a rare association. Orbit. 2014;33(1):62–64. doi: 10.3109/01676830.2013.842255
   PubMedGoogle Scholar
• Dabrowska M, Krenke R, Maskey-Warzechowska M, et al. Primary immune thrombocytopenia in a patient with sarcoidosis. Pneumonol Alergol Pol. 2011;79(5):371–376. doi: 10.5603/ARM.27640
   PubMedGoogle Scholar
• Agarwal V, Pal S, Agarwal A, et al. Thrombocytopenia as the presenting manifestation of sarcoidosis. J Assoc Physicians India. 2002;50:268–269.
   PubMedGoogle Scholar
• Nakano T, Fukuyama S, Inoue K, et al. A case of sarcoidosis and idiopathic thrombocytopenic purpura accompanied with invasive pulmonary aspergillosis. Nihon Kokyuki Gakkai Zasshi. 2002;40(12):945–949.
   PubMedGoogle Scholar
• Takahashi T, Kazama Y, Shimizu H, et al. Association of idiopathic thrombocytopenic purpura and type 1 diabetes mellitus in a patient with sarcoidosis. Nihon Rinsho Meneki Gakkai Kaishi. 2001;24(2):81–86.
   PubMedGoogle Scholar
• Kondo H, Sakai S, Sakai Y. Autoimmune haemolytic anaemia, Sjogren’s syndrome and idiopathic thrombocytopenic purpura in a patient with sarcoidosis. Acta Haematol. 1993;89(4):209–212. doi: 10.1159/000204526
   PubMed Web of Science ®Google Scholar
• Fujisawa N, Katoh O, Yamaguchi T, et al. A case of cardiac sarcoidosis associated with various clinical symptoms and thrombocytopenia. Nihon Kokyuki Gakkai Zasshi. 1992;30(12):2146–2150.
   Google Scholar
• Hisada M, Okamoto S, Nakajima H, et al. Chronic immune thrombocytopenia in sarcoidosis. Keio J Med. 1990;39(4):261–264. doi: 10.2302/kjm.39.261
   PubMedGoogle Scholar
• Larner AJ, Dollery CT, Cox TM, et al. Life threatening thrombocytopenia in sarcoidosis. BMJ. 1990;300(6720):317–319. doi: 10.1136/bmj.300.6720.317
   PubMedGoogle Scholar
• Lawrence HJ, Greenberg BR. Autoimmune thrombocytopenia in sarcoidosis. Am J Med. 1985;79(6):761–764. doi: 10.1016/0002-9343(85)90528-5
   PubMed Web of Science ®Google Scholar
• VanSlyck EJ, Dasgupta D. Sarcoidosis and idiopathic thrombocytopenic purpura. First report of coexistence. Henry Ford Hosp Med J. 1969;17(2):93–100.
   PubMedGoogle Scholar
• CRANE AR, ZETLIN AM. Hemolytic anemia, hyperglobulinemia and Boeck’s sarcoid. Ann Intern Med. 1945;23:882–889.
   PubMed Web of Science ®Google Scholar
• Chernow K, Donegan T, Milman T, et al. Sarcoidosis, complete heart block, and warm autoimmune hemolytic anemia in a young woman. J Community Support Oncol. 2015;13(4):159–161. doi: 10.12788/jcso.0128
   Google Scholar
• Ghaddar RK, Muzaffar TH. Pulmonary sarcoidosis and autoimmune hemolytic anemia: possible common immune pathogenesis. Arch Iran Med. 2011;14(2):146–148.
   PubMed Web of Science ®Google Scholar
• Zaina A, Horn I, Manaster O, et al. Sarcoidosis with cholangitis component in a patient with autoimmune hemolytic anemia. Isr Med Assoc J. 2000;2(9):712.
   PubMed Web of Science ®Google Scholar
• Green S, Partridge E, Idedevbo E, et al. Steroid refractory autoimmune haemolytic anaemia secondary to sarcoidosis successfully treated with rituximab and mycophenolate mofetil. Case Rep Hematol. 2016;2016:9495761. doi: 10.1155/2016/9495761
   PubMedGoogle Scholar
• Bader-Meunier B, Fabre M, Gauthier F, et al. Sarcoidosis with hematologic involvement and hypogammaglobulinemia. Arch Pediatr. 1996;3(6):576–579. doi: 10.1016/0929-693X(96)83231-3
   PubMed Web of Science ®Google Scholar
• Yasuda N, Kohda M, Nomura M, et al. Sarcoidosis in a patient with autoimmune hemolytic anemia. Nihon Kokyuki Gakkai Zasshi. 1996;34(8):931–936.
   Google Scholar
• Taillan B, Pedinielli FJ, Routy JP, et al. Non-Hodgkin malignant lymphoma and autoimmune anemia during the development of sarcoidosis. La Rev Med interne. 1985;6(5):573–575. doi: 10.1016/s0248-8663(85)80040-0
   PubMed Web of Science ®Google Scholar
• Desablens B, Pruna A, Gontier MF, et al. Autoimmune haemolytic anaemia associated with bone marrow sarcoidosis. Acta Haematol. 1984;71(3):204–206. doi: 10.1159/000206585
   PubMed Web of Science ®Google Scholar
• Lee CA. Acquired hypogammaglobulinaemia and sarcoidosis. Postgrad Med J. 1984;60(706):551–553. doi: 10.1136/pgmj.60.706.551
   PubMed Web of Science ®Google Scholar
• Semple P. Thrombocytopenia, haemolytic anaemia, and sarcoidosis. Br Med J. 1975;4(5994):440–441. doi: 10.1136/bmj.4.5994.440-a
   PubMedGoogle Scholar
• WLJ COX, DONALD JMJ. ACQUIRED HEMOLYTIC ANEMIA and BOECK’S SARCOIDOSIS. REVIEW of the LITERATURE. Am Surg. 1964;30:199–202.
   PubMedGoogle Scholar
• West WO. Acquired hemolytic anemia secondary to Boeck’s sarcoid. Report of a case and review of the literature. N Engl J Med. 1959;261(14):688–690. doi: 10.1056/NEJM195910012611403
   PubMed Web of Science ®Google Scholar
• DAVIS AE, BELBER JP, MOVITT ER. Case Report: the association of hemolytic anemia with Sarcoidosis. Blood. 1954;9(4):379–383. doi: 10.1182/blood.V9.4.379.379
   PubMed Web of Science ®Google Scholar
• Selroos O, Koivunen E. Prognostic significance of lymphopenia in sarcoidosis. Acta Med Scand. 1979;206(4):259–262. doi: 10.1111/j.0954-6820.1979.tb13507.x
   PubMedGoogle Scholar
• Jones NP, Tsierkezou L, Patton N. Lymphopenia as a predictor of sarcoidosis in patients with uveitis. Br J Ophthalmol. 2016;100(10):1393–1396. doi: 10.1136/bjophthalmol-2015-307455
   PubMed Web of Science ®Google Scholar
• Valeyre D, Casassus P, Battesti JP. Clinical value of the blood lymphocyte count in thoracic sarcoidosis in adults. Apropos of 123 cases. Rev Pneumol Clin. 1984;40(1):13–19.
   PubMedGoogle Scholar
• Sweiss NJ, Salloum R, Gandhi S, et al. Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations. PLoS One. 2010;5(2):e9088. doi: 10.1371/journal.pone.0009088
   PubMed Web of Science ®Google Scholar
• Morell F, Levy G, Orriols R, et al. Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis. Chest. 2002;121(4):1239–1244. doi: 10.1378/chest.121.4.1239
   PubMed Web of Science ®Google Scholar
• Cohen-Aubart F, Galanaud D, Grabli D, et al. Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine (Baltimore). 2010;89(2):133–140. doi: 10.1097/MD.0b013e3181d5c6b4
   PubMed Web of Science ®Google Scholar
• Groen-Hakan F, Eurelings L, Rothova A, et al. Lymphopaenia as a predictor of sarcoidosis in patients with a first episode of uveitis. Br J Ophthalmol. 2019;103(9):1296–1300. doi: 10.1136/bjophthalmol-2018-313212
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Smith JR, Takase H, et al. Revised criteria of International Workshop on Ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418–1422. doi: 10.1136/bjophthalmol-2018-313356
   PubMed Web of Science ®Google Scholar
• Crouser ED, Lozanski G, Fox CC, et al. The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy. Chest. 2010;137(6):1432–1435. doi: 10.1378/chest.09-2576
   PubMed Web of Science ®Google Scholar
• Chaudhary P, Gopaluni S, Sanyal S, et al. Atypical sarcoidosis masquerading as neutropenia. Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG. 2010;27(2):160–163.
   PubMed Web of Science ®Google Scholar
• Cuilliere-Dartigues P, Meyohas M-C, Balladur P, et al. Splenic sarcoidosis: an unusual aetiology of agranulocytosis. Am J Hematol. 2010;85(11):891. doi: 10.1002/ajh.21661
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Retamozo S, Siso-Almirall A, et al. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Rev Clin Immunol. 2019;15(4):391–405. doi: 10.1080/1744666X.2019.1568240
   PubMed Web of Science ®Google Scholar
• Arish N, Kuint R, Sapir E, et al. Characteristics of sarcoidosis in patients with previous malignancy: causality or coincidence? Respiration. 2017;93(4):247–252. doi: 10.1159/000455877
   PubMed Web of Science ®Google Scholar
• Holmqvist AS, Olsen JH, Mellemkjaer L, et al. Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS). Ann Rheum Dis. 2016;75(9):1622–1629. doi: 10.1136/annrheumdis-2015-207659
   PubMed Web of Science ®Google Scholar
• Alzghoul BN, Zayed Y, Obeidat A, et al. Clinical characteristics of sarcoidosis patients with self-reported lymphoma: a US nationwide registry study. Lung. 2021;199(6):611–618. doi: 10.1007/s00408-021-00485-z
   PubMed Web of Science ®Google Scholar
• Kadin ME, Glatstein E, Dorfman RF. Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin’s disease. Cancer. 1971;27(6):1277–1294. doi: 10.1002/1097-0142(197106)27:6<1277:AID-CNCR2820270602>3.0.CO;2-T
   PubMed Web of Science ®Google Scholar
• Kim H, Dorfman RF. Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin’s lymphomas. Cancer. 1974;33(3):657–674. doi: 10.1002/1097-0142(197403)33:3<657:aid-cncr2820330311>3.0.co;2-d
   PubMed Web of Science ®Google Scholar
• Cerri S, Fontana M, Balduzzi S, et al. Clinical differences in sarcoidosis patients with and without lymphoma: a single-centre retrospective cohort analysis. Eur Respir J. 2019;54(5):1802470. doi: 10.1183/13993003.02470-2018
   PubMed Web of Science ®Google Scholar
• Blank N, Lorenz H-M, Ho AD, et al. Sarcoidosis and the occurrence of malignant diseases. Rheumatol Int. 2014;34(10):1433–1439. doi: 10.1007/s00296-014-2983-5
   PubMed Web of Science ®Google Scholar
• Boffetta P, Rabkin CS, Gridley G. A cohort study of cancer among sarcoidosis patients. Int J Cancer. 2009;124(11):2697–2700. doi: 10.1002/ijc.24261
   PubMed Web of Science ®Google Scholar
• Sogaard KK, Svaerke C, Thomsen RW, et al. Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study. Eur Respir J. 2015;45(1):269–272. doi: 10.1183/09031936.00084414
   PubMed Web of Science ®Google Scholar
• Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2069–2077. doi: 10.1158/1055-9965.EPI-06-0300
   PubMed Web of Science ®Google Scholar
• Ekström Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029–4038. doi: 10.1182/blood-2007-10-119974
   PubMed Web of Science ®Google Scholar
• Fallah M, Liu X, Ji J, et al. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol Off J Eur Soc Med Oncol. 2014;25(10):2025–2030. doi: 10.1093/annonc/mdu365
   PubMed Web of Science ®Google Scholar
• Ji J, Shu X, Li X, et al. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol. 2009;20(6):1121–1126. doi: 10.1093/annonc/mdn767
   PubMed Web of Science ®Google Scholar
• Faurschou M, Omland LH, Obel N, et al. Risk of cancer among sarcoidosis patients with biopsy-verified nonnecrotizing granulomatous inflammation: population-based cohort study. J Rheumatol. 2022;49(2):186–191. doi: 10.3899/jrheum.210588
   PubMed Web of Science ®Google Scholar
• Landgren O, Engels EA, Pfeiffer RM, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst. 2006;98(18):1321–1330. doi: 10.1093/jnci/djj361
   PubMedGoogle Scholar
• Tiago Serra J, Martinho A, Paixao Duarte F, et al. Sarcoidosis and Multiple Myeloma: A Case Report and Literature Review. Case Rep Hematol. 2019;2019:4586265. doi: 10.1155/2019/4586265
   PubMed Web of Science ®Google Scholar
• Brandt L, Emanuelsson H, Mitelman F, et al. Pronounced deficiency in T-cells and lymphocyte chromosomal aberrations in a patient with sarcoidosis, myelofibrosis and acute leukaemia following thorotrast angiography. Acta Med Scand. 1977;201(5):487–489. doi: 10.1111/j.0954-6820.1977.tb15734.x
   PubMedGoogle Scholar
• Pagano L, Visani G, Ferrara F, et al. Contemporaneous acute myeloid leukaemia and sarcoidosis. Report of three cases. Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG. 1998;15(1):67–70.
   PubMed Web of Science ®Google Scholar
• Wajima T. Hemoglobin C/beta+ thalassemia and sarcoidosis. Am J Hematol. 1995;50(3):228–229. doi: 10.1002/ajh.2830500320
   PubMed Web of Science ®Google Scholar
• Nutan F, Gollahalli NS. Coexisting Sickle Cell Anemia and Sarcoidosis: A Management Conundrum! Clin Med Insights Blood Disord. 2017;10:1179545X16685314. doi: 10.1177/1179545X16685314
   PubMedGoogle Scholar
• Delmonte L, Zamo A, Cantini M, et al. An unusual case of sarcoidosis in an adult patient with sickle cell disease: management with methotrexate and low dose of steroid. Am J Hematol. 2013;88(3):243. doi: 10.1002/ajh.23378
   PubMed Web of Science ®Google Scholar
• Froidure A, Horsmans Y, Lefebvre C. Multisystemic sarcoidosis associated with a second therapy for chronic hepatitis C. Acta Gastroenterol Belg. 2009;72(2):249–251.
   PubMed Web of Science ®Google Scholar
• Lehmann LH, Riess H, Sturm I. Sickle cell disease, pulmonary hypertension, and sarcoidosis. Ann Hematol. 2008;87(7):591–592. doi: 10.1007/s00277-008-0437-4
   PubMed Web of Science ®Google Scholar
• Güvenç B, Unsal C, Hanta I, et al. Sickle cell anemia patient with sarcoidosis-associated inguinal lymph node and lung infiltration. J Natl Med Assoc. 2005;97(6):820–822.
   PubMedGoogle Scholar
• Robinson KJ, Cury JD, Laos LF. Bronchial stricture and hemoptysis in a woman with sickle cell anemia. Chest. 2004;125(2):766–769. doi: 10.1378/chest.125.2.766
   PubMed Web of Science ®Google Scholar
• Chan ED, Terada LS, Schwarz MI. Sarcoidosis presenting with prolonged fever in a patient with sickle cell anemia. J Natl Med Assoc. 1995;87(11):826–828.
   PubMed Web of Science ®Google Scholar
• Zwerdling T, Kalinyak K, Rucknagel D. Sarcoidosis in a child with sickle cell anemia. Am J Pediatr Hematol Oncol. 1994;16(3):278–282. doi: 10.1097/00043426-199408000-00018
   PubMedGoogle Scholar
• Hall G, Carter J. Sarcoidosis and sickle cell disease. Ann Intern Med. 1993;118(2):157–158. doi: 10.7326/0003-4819-118-2-199301150-00025
   PubMed Web of Science ®Google Scholar
• Guillaud R, Grasset A, Marty-Double C, et al. Mediastinal adenopathy as a sign of sarcoidosis in a child with sickle cell-thalassemia. Ann Pediatr (Paris). 1986;33(1):67–70.
   PubMedGoogle Scholar
• Madigan JCJ, Gragoudas ES, Schwartz PL, et al. Peripheral retinal neovascularization in sarcoidosis and sickle cell anemia. Am J Ophthalmol. 1977;83(3):387–391. doi: 10.1016/0002-9394(77)90738-3
   PubMed Web of Science ®Google Scholar
• HIRSCHMAN RJ, JOHNS CJ. HEMOGLOBIN STUDIES IN SARCOIDOSIS. Ann Intern Med. 1965;62(1):129–132. doi: 10.7326/0003-4819-62-1-129
   PubMed Web of Science ®Google Scholar
• GREENBERG SR, ATWATER J, ISRAEL HL. FREQUENCY OF HEMOGLOBINOPATHIES IN SARCOIDOSIS. Ann Intern Med. 1965;62(1):125–128. doi: 10.7326/0003-4819-62-1-125
   PubMed Web of Science ®Google Scholar
• Flores-Chavez A, Ng W-F, Alunno A, et al. Characterisation of the coexistence between sarcoidosis and Sjögren’s syndrome. Analysis of 43 patients. Clin Exp Rheumatol. 2022;40(12):2329–2337. doi: 10.55563/clinexprheumatol/pg964c
   PubMed Web of Science ®Google Scholar
• Jih DM, Werth VP. Thrombocytopenia after a single test dose of methotrexate. J Am Acad Dermatol. 1998;39(2 Pt 2):349–351. doi: 10.1016/S0190-9622(98)70387-1
   PubMed Web of Science ®Google Scholar
• Mahevas M, Chiche L, Uzunhan Y, et al. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients. Medicine (Baltimore). 2011;90(4):269–278. doi: 10.1097/MD.0b013e31822618b3
   PubMed Web of Science ®Google Scholar
• Patel SR. Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report. J Med Case Rep. 2009;3(1):8573. doi: 10.4076/1752-1947-3-8573
   PubMedGoogle Scholar
• Dickerman JD, Holbrook PR, Zinkham WH. Etiology and therapy of thrombocytopenia associated with sarcoidosis. J Pediatr. 1972;81(4):758–764. doi: 10.1016/S0022-3476(72)80098-2
   PubMed Web of Science ®Google Scholar
• Mahevas M, Le Page L, Salle V, et al. Thrombocytopenia in sarcoidosis. Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG/World Assoc Sarcoidosis Other Granulomatous Disord. 2006;23(3):229–235.
   PubMed Web of Science ®Google Scholar
• Warshauer DM. Splenic sarcoidosis. Semin Ultrasound CT MR. 2007;28(1):21–27. doi: 10.1053/j.sult.2006.10.004
   PubMed Web of Science ®Google Scholar
• Nusair S, Kramer MR, Berkman N. Pleural effusion with splenic rupture as manifestations of recurrence of sarcoidosis following prolonged remission. Respiration. 2003;70(1):114–117. doi: 10.1159/000068424
   PubMed Web of Science ®Google Scholar
• Judson MA. Corticosteroids in sarcoidosis. Rheum Dis Clin North Am. 2016;42(1):119–135, ix. doi: 10.1016/j.rdc.2015.08.012
   PubMed Web of Science ®Google Scholar
• Sharma OP, Vucinic V, James DG. Splenectomy in sarcoidosis: indications, complications, and long-term follow-up. Sarcoidosis, Vasc Diffus Lung Dis Off J WASOG/World Assoc Sarcoidosis Other Granulomatous Disord. 2002;19(1):66–70.
   PubMed Web of Science ®Google Scholar
• Souto MM, Tempes BC, Lambert BF, et al. Laparoscopic splenectomy for isolated splenic sarcoidosis. JSLS J Soc Laparoendosc Surg. 2014;18(1):155–159. doi: 10.4293/108680814X13868878212956
   Google Scholar
• Madaule S, Lauque D, Sailler L, et al. Splenomegaly in sarcoidosis: clinical features and outcome. Analysis of 17 cases. La Rev Med interne. 2004;25(5):348–356. doi: 10.1016/j.revmed.2003.11.007
   PubMed Web of Science ®Google Scholar